BN Business News
Add your company to Business Communicator →

Business · 25/04/2006Updated: 10/17/2026 · 1 min read

FDA Releases Guidance on Informed Consent for In Vitro Diagnostic Device Studies Using Non-Identifiable Human Specimens

Summary

The FDA has announced the availability of a guidance document that outlines circumstances under which the agency will not object to the use of leftover, non-individually identifiable human specimens in device investigations without informed consent.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →